🇺🇸 PFE — Pfizer Inc.

Healthcare Compra
← Volver

Precio actual

27,79 USD

Máx. histórico

61,71

1723 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-54,97%

Rango 52 semanas

23,58 – 29,21

Variación hoy

-2,32%

Cierre anterior

28,45

Rango de hoy

27,72 – 28,15

Volumen hoy

31.727.745

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
75.000
PER
36,57 (puede no estar actualizado)
Dividend yield
6,05% (puede no estar actualizado)
Precio objetivo analistas
28,61 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 2 horas
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,7200 USD · Yield: 6,19%
Fecha de pago Importe por participación
31/07/1996 0,0474 USD
08/05/1996 0,0474 USD
07/02/1996 0,0474 USD
08/11/1995 0,0411 USD
02/08/1995 0,0411 USD
08/05/1995 0,0411 USD
06/02/1995 0,0411 USD
04/11/1994 0,0372 USD
01/08/1994 0,0372 USD
09/05/1994 0,0372 USD
07/02/1994 0,0372 USD
05/11/1993 0,0332 USD
02/08/1993 0,0332 USD
10/05/1993 0,0332 USD
08/02/1993 0,0332 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/01/2004 34,28 34,85 34,11 34,21 -1,07% 2,16% 16.779.996
08/01/2004 34,91 34,93 34,22 34,58 -0,92% 2,04% 19.021.116
07/01/2004 34,36 34,91 34,30 34,91 +0,85% 1,79% 17.674.631
06/01/2004 34,91 34,91 34,39 34,61 -0,05% 1,49% 24.440.047
05/01/2004 34,13 34,63 34,11 34,63 +2,67% 1,53% 32.349.052
02/01/2004 33,61 34,11 33,54 33,73 +0,62% 1,69% 17.461.513
31/12/2003 33,23 33,58 33,23 33,52 +0,74% 1,06% 14.613.288
30/12/2003 33,21 33,52 33,08 33,27 +0,20% 1,31% 18.642.941
29/12/2003 32,98 33,21 32,97 33,21 +0,72% 0,72% 14.166.919
26/12/2003 32,94 33,10 32,88 32,97 +0,09% 0,66% 4.109.019
24/12/2003 32,82 33,15 32,79 32,94 +0,58% 1,10% 7.519.763
23/12/2003 32,55 32,87 32,53 32,75 +0,64% 1,05% 14.581.563
22/12/2003 32,31 32,91 32,28 32,54 +0,09% 1,97% 18.582.442
19/12/2003 32,68 32,68 32,27 32,51 -0,49% 1,25% 33.229.880
18/12/2003 32,73 32,75 32,46 32,68 +0,26% 0,90% 17.642.274
17/12/2003 32,72 32,81 32,48 32,59 -0,72% 1,01% 16.523.663
16/12/2003 32,69 33,02 32,68 32,83 +0,46% 1,05% 17.001.336
15/12/2003 32,78 33,25 32,59 32,68 +0,12% 2,03% 17.395.111
12/12/2003 32,90 32,96 32,50 32,64 -0,81% 1,38% 11.952.782
11/12/2003 32,39 32,97 32,23 32,90 +1,70% 2,28% 20.278.538
10/12/2003 32,50 32,78 32,16 32,35 -0,84% 1,90% 13.192.918
09/12/2003 32,73 32,93 32,55 32,63 -0,12% 1,16% 18.484.736
08/12/2003 32,26 32,69 32,21 32,67 +0,67% 1,47% 13.708.008
05/12/2003 32,62 32,68 32,32 32,45 -0,49% 1,08% 13.211.468
04/12/2003 32,37 32,73 32,30 32,61 +1,24% 1,35% 21.514.353
03/12/2003 32,36 32,63 32,19 32,21 -0,24% 1,35% 23.145.418
02/12/2003 32,14 32,48 32,14 32,29 -0,41% 1,03% 14.418.825
01/12/2003 32,33 32,54 32,12 32,42 +1,79% 1,32% 19.912.590
28/11/2003 31,74 32,03 31,71 31,85 -0,77% 1,02% 8.410.709
26/11/2003 32,07 32,30 31,78 32,10 +0,15% 1,60% 16.369.990